Purchases and Sales Made in Q3 2025 in Xilio Therapeutics, Inc. (XLO)
This table provides information about the institutional ownership of Xilio Therapeutics, Inc. (XLO) during Q3 2025. The information is specifically focused on institutions that hold shares of Xilio Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 14, 2025
Q3 2025
|
State Street Corp
Boston, MA |
BUY
|
- |
121K+ 277.71% |
$78.3K - $104K
|
164K
$115K
|
|
|
Nov 07, 2025
Q3 2025
|
Vanguard Group Inc
Valley Forge, PA |
BUY
|
- |
105K+ 9.09% |
$68K - $90K
|
1.26M
$879K
|
|
|
Nov 14, 2025
Q3 2025
|
Squarepoint Ops LLC
New York, NY |
BUY
|
- |
93.3K+ 39.64% |
$60.7K - $80.3K
|
329K
$230K
|
|
|
Nov 14, 2025
Q3 2025
|
Xtx Topco LTD
London, X0 |
BUY
|
- |
41.3K+ 119.02% |
$26.9K - $35.5K
|
76K
$53.2K
|
|
|
Nov 13, 2025
Q3 2025
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
BUY
|
- |
40.5K+ 24.67% |
$26.3K - $34.8K
|
205K
$143K
|
|
|
Nov 14, 2025
Q3 2025
|
Two Sigma Securities, LLC
New York, NY |
BUY
|
- |
32.1KNew |
$20.9K - $27.6K
|
32.1K
$22.5K
|
|
|
Nov 14, 2025
Q3 2025
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
BUY
|
- |
29.7KNew |
$19.3K - $25.5K
|
29.7K
$20.8K
|
|
|
Nov 14, 2025
Q3 2025
|
Hrt Financial LP
New York, NY |
BUY
|
- |
24.7KNew |
$16.1K - $21.3K
|
24.7K
$17.3K
|
|
|
Nov 14, 2025
Q3 2025
|
Two Sigma Investments, LP
New York, NY |
BUY
|
- |
9.76K+ 12.51% |
$6.34K - $8.39K
|
87.8K
$61.5K
|
|
|
Nov 10, 2025
Q3 2025
|
Citigroup Inc
|
BUY
|
- |
258New |
$168 - $222
|
258
$181
|
|
|
Nov 14, 2025
Q3 2025
|
Bank Of America Corp
Charlotte, NC |
SELL
|
- |
-85- 25.68% |
$55.3 - $73.1
|
246
$172
|
|
|
Nov 12, 2025
Q3 2025
|
Geode Capital Management, LLC
Boston, MA |
SELL
|
- |
-40.7K- 11.01% |
$26.4K - $35K
|
329K
$230K
|
|
|
Nov 13, 2025
Q3 2025
|
Ubs Group Ag
|
SELL
|
- |
-226K- 94.31% |
$147K - $195K
|
13.7K
$9.56K
|
|
|
Nov 14, 2025
Q3 2025
|
Morgan Stanley
New York, NY |
SELL
|
- |
-482K- 33.4% |
$314K - $415K
|
962K
$673K
|
|